Displaying 1 publication

Abstract:
Sort:
  1. Bibi A, Alam A, Fareed G, Ayaz M, Shah TA, Naz S, et al.
    Future Med Chem, 2026 Apr;18(8):881-893.
    PMID: 41808456 DOI: 10.1080/17568919.2026.2642677
    AIMS: Cyclooxygenase-2 (COX-2) is a key enzyme in pain perception and inflammatory cascade that make it an attractive target to develop safer anti-inflammatory agents.

    METHOD: In pursuit of potential anti-inflammatory agents, a new series based on α-naphthalene acetic acid has been synthesized through multi step reactions process. 1H-NMR and 13C-NMR spectroscopic techniques were used to confirm the structures of these derivatives.

    RESULTS: These compounds have been assessed for their in vitro COX-2 inhibitory activity, among them, compounds (4, 5, 13, and 3) exhibited excellent activity with IC50 value ranging from (IC50 = 0.36 ± 0.22 µM) to (IC50 = 0.43 ± 0.60 µM), while compounds (12, 11, and 14) showed significant activity.

    DISCUSSION: The molecular docking and density functional theory (DFT) analyses exposed that hydrazide derivatives based on α-naphthylene acetic acid displayed strong binding affinity for COX-2. Compound 13 revealed the highest binding energy of -9.771 kJ mol-1 and the lowest IC50 (0.43 µM) over π-π interactions and multiple hydrogen bonds. DFT study exposed that compound 13 influenced the highest softening and the smallest HOMO-LUMO energy gap, representing improved reactivity.

    CONCLUSION: In general, the computational as well as experimental consequences specify that compound 13 is a potent COX-2 inhibitor.

Related Terms
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links